Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Burning Rock Biotech Ltd ADR (NQ: BNR )

0.9900 +0.0550 (+5.88%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Burning Rock Biotech Ltd ADR

Burning Rock's minimal residual disease (MRD) product supports advancement in early-stage non-small cell lung cancer treatment, with results published in the Cancer Cell
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Reports Second Quarter 2023 Financial Results
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Provides Second Quarter 2023 Business Updates and Schedules Earnings Release on August 31, 2023
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Announces Resignation and Appointment of Directors
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock's precision oncology diagnostics product supports advancement in late-stage breast cancer treatment, with results published in the New England Journal of Medicine
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Reports First Quarter 2023 Financial Results
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Provides First Quarter 2023 Business Updates and Schedules Earnings Release on May 30, 2023
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Publishes 2022 Annual Report on Form 20-F
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Reports Fourth Quarter and Full Year 2022 Financial Results
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Schedules Fourth Quarter and Full Year 2022 Earnings Release on March 28, 2023
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock provides an update on 2022 revenue guidance
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Received FDA Breakthrough Device Designation for its OverC™ Multi-Cancer Detection Blood Test
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Reports Third Quarter 2022 Financial Results
From Burning Rock Biotech Limited
Via GlobeNewswire
Admission to Trading on the London Stock Exchange
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Announces Publication of Prospectus in connection with Direct Listing on the London Stock Exchange
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Provides Third Quarter 2022 Business Updates and Schedules Earnings Release on November 16, 2022
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Announces Publication of Registration Document and Potential Direct Listing on the London Stock Exchange
From Burning Rock Biotech Limited
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.